Cargando…

Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction

Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Luyi, Sun, Wei-Lun, See, Ronald E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755900/
https://www.ncbi.nlm.nih.gov/pubmed/23997653
http://dx.doi.org/10.3390/ph4060804
_version_ 1782282006211592192
author Zhou, Luyi
Sun, Wei-Lun
See, Ronald E.
author_facet Zhou, Luyi
Sun, Wei-Lun
See, Ronald E.
author_sort Zhou, Luyi
collection PubMed
description Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors offers a promising target for addiction treatment. Growing evidence has implicated an important role of the orexin/hypocretin system in drug reward and drug-seeking, including animal models of relapse. Here, we review the evidence for the role of orexins in modulating reward and drug-seeking in animal models of addiction and the potential for orexin receptors as specific targets for anti-relapse medication approaches.
format Online
Article
Text
id pubmed-3755900
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-37559002013-08-28 Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction Zhou, Luyi Sun, Wei-Lun See, Ronald E. Pharmaceuticals (Basel) Review Drug addiction is a chronic illness characterized by high rates of relapse. Relapse to drug use can be triggered by re-exposure to drug-associated cues, stressful events, or the drug itself after a period of abstinence. Pharmacological intervention to reduce the impact of relapse-instigating factors offers a promising target for addiction treatment. Growing evidence has implicated an important role of the orexin/hypocretin system in drug reward and drug-seeking, including animal models of relapse. Here, we review the evidence for the role of orexins in modulating reward and drug-seeking in animal models of addiction and the potential for orexin receptors as specific targets for anti-relapse medication approaches. MDPI 2011-06-14 /pmc/articles/PMC3755900/ /pubmed/23997653 http://dx.doi.org/10.3390/ph4060804 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Review
Zhou, Luyi
Sun, Wei-Lun
See, Ronald E.
Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title_full Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title_fullStr Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title_full_unstemmed Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title_short Orexin Receptor Targets for Anti-Relapse Medication Development in Drug Addiction
title_sort orexin receptor targets for anti-relapse medication development in drug addiction
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755900/
https://www.ncbi.nlm.nih.gov/pubmed/23997653
http://dx.doi.org/10.3390/ph4060804
work_keys_str_mv AT zhouluyi orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction
AT sunweilun orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction
AT seeronalde orexinreceptortargetsforantirelapsemedicationdevelopmentindrugaddiction